LX-6171

CAS No. 914808-66-5

LX-6171( —— )

Catalog No. M34323 CAS No. 914808-66-5

LX-6171, a proline transporter (SLC6A7) inhibitor, is used potentially for the treatment of schizophrenia and Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 217 Get Quote
5MG 342 Get Quote
10MG 504 Get Quote
25MG 790 Get Quote
50MG 1086 Get Quote
100MG 1431 Get Quote
500MG 2871 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LX-6171
  • Note
    Research use only, not for human use.
  • Brief Description
    LX-6171, a proline transporter (SLC6A7) inhibitor, is used potentially for the treatment of schizophrenia and Alzheimer's disease.
  • Description
    LX-6171, a proline transporter (SLC6A7) inhibitor, is used potentially for the treatment of schizophrenia and Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    914808-66-5
  • Formula Weight
    377.87
  • Molecular Formula
    C22H20ClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC=1C=C(C2=CC=C(C(=O)C3CCN(CC3)C=4N=CC=CN4)C=C2)C=CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N'-Methylnicotinamid...

    N-methylnicotinamide is a metabolite of niacin (or nicotinamide) and is commonly found in human urine. However low levels of urinary excretion of N-methylnicotinamide indicates niacin deficiency. In patients with liver cirrhosis nicotinamide methylation is increased leading to a rise in urinary N-methylnicotinamide. N-methylnicotinamide has been found to be a microbial metabolite.

  • HARMANE

    Harmane (harman) is a bio-active β-Carboline and monoamine oxidase inhibitor found in coffee and tobacco smoke.

  • HET0016

    HET0016 is a potent and selective 20-HETE synthase inhibitor (IC50s: 17.7 nM, 12.1 nM, and 20.6 nM for recombinant CYP4A1-, CYP4A2-, and CYP4A3-catalyzed 20-HETE synthesis) and a selective CYP450 inhibitor, shown to inhibit angiogenesis and tumor growth.